Whole-body MRI compared with standard pathways for staging metastatic disease in lung and colorectal cancer: the Streamline diagnostic accuracy studies.
暂无分享,去创建一个
Steve Halligan | Vicky Goh | Susan Mallett | Shonit Punwani | Neal Navani | Dow-Mu Koh | Anne Miles | John Bridgewater | Stephen Morris | Stuart A Taylor | Sandy Beare | Andrea Rockall | V. Goh | A. Padhani | D. Koh | S. Punwani | S. Halligan | J. Bridgewater | A. Miles | S. Mallett | A. Rockall | S. Janes | S. Beare | N. Navani | Alf Oliver | S. Morris | Laura Quinn | Caroline S Clarke | Sam Janes | Alison Morton | Alfred Oliver | Anwar Padhani | C. Clarke | Alison Morton | L. Quinn | S. Taylor | A. Oliver
[1] H. Groen,et al. The Accuracy of Clinical Staging of Stage I-IIIa Non-Small Cell Lung Cancer An Analysis Based on Individual Participant Data , 2018 .
[2] H. Sørensen,et al. The impact of comorbidity on cancer survival: a review , 2013, Clinical epidemiology.
[3] Yong Xu,et al. Diagnosis of bone metastases: a meta-analysis comparing 18FDG PET, CT, MRI and bone scintigraphy , 2011, European Radiology.
[4] H. Groen,et al. Distress in suspected lung cancer patients following rapid and standard diagnostic programs: a prospective observational study , 2015, Psycho-oncology.
[5] D. Borowski,et al. The NHS Bowel cancer screening programme achieves the anticipated survival improvement, but participation must be improved. , 2018, International journal of health care quality assurance.
[6] P. Salmon,et al. Evaluating customer satisfaction with colonoscopy. , 1994, Endoscopy.
[7] Chaya S Moskowitz,et al. Sample size calculations for comparative studies of medical tests for detecting presence of disease , 2002, Statistics in medicine.
[8] R G Newcombe,et al. Improved confidence intervals for the difference between binomial proportions based on paired data. , 1998, Statistics in medicine.
[9] J. Stoker,et al. Diagnostic imaging of colorectal liver metastases with CT, MR imaging, FDG PET, and/or FDG PET/CT: a meta-analysis of prospective studies including patients who have not previously undergone treatment. , 2010, Radiology.
[10] V. Goh,et al. Patient preferences for whole-body MRI or conventional staging pathways in lung and colorectal cancer: a discrete choice experiment , 2019, European Radiology.
[11] J. Louviere,et al. Conducting Discrete Choice Experiments to Inform Healthcare Decision Making , 2012, PharmacoEconomics.
[12] P Boffetta,et al. Socioeconomic differences in cancer incidence and mortality. , 1997, IARC scientific publications.
[13] S. Park,et al. Diagnostic performance of CT, gadoxetate disodium‐enhanced MRI, and PET/CT for the diagnosis of colorectal liver metastasis: Systematic review and meta‐analysis , 2018, Journal of magnetic resonance imaging : JMRI.
[14] Andrew Lloyd,et al. Conjoint analysis applications in health--a checklist: a report of the ISPOR Good Research Practices for Conjoint Analysis Task Force. , 2011, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
[15] Bas Donkers,et al. Sample Size Requirements for Discrete-Choice Experiments in Healthcare: a Practical Guide , 2015, The Patient - Patient-Centered Outcomes Research.
[16] R. Beets-Tan,et al. The Diagnostic Value of MR Imaging in Determining the Lymph Node Status of Patients with Non-Small Cell Lung Cancer: A Meta-Analysis. , 2016, Radiology.
[17] P. Asbach,et al. Whole-body MR imaging versus sequential multimodal diagnostic algorithm for staging patients with rectal cancer: cost analysis. , 2010, RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin.
[18] Ross G Menzies,et al. Predicting anxiety in magnetic resonance imaging scans , 2004, International journal of behavioral medicine.
[19] M. Holmes-Rovner,et al. Do self-report and medical record comorbidity data predict longitudinal functional capacity and quality of life health outcomes similarly? , 2012, BMC Health Services Research.
[20] O. Dalesio,et al. Preoperative chemotherapy in patients with resectable non-small cell lung cancer: results of the MRC LU22/NVALT 2/EORTC 08012 multicentre randomised trial and update of systematic review , 2007, The Lancet.
[21] P. Bossuyt,et al. Evaluation of diagnostic tests when there is no gold standard. A review of methods. , 2007, Health technology assessment.
[22] P. Ellis,et al. Understanding the Needs of Colorectal Cancer Patients during the Pre-diagnosis Phase , 2013, Journal of Cancer Education.
[23] S. Matsumoto,et al. Three-way Comparison of Whole-Body MR, Coregistered Whole-Body FDG PET/MR, and Integrated Whole-Body FDG PET/CT Imaging: TNM and Stage Assessment Capability for Non-Small Cell Lung Cancer Patients. , 2015, Radiology.
[24] Stuart A. Taylor,et al. Streamlining staging of lung and colorectal cancer with whole body MRI; study protocols for two multicentre, non-randomised, single-arm, prospective diagnostic accuracy studies (Streamline C and Streamline L) , 2017, BMC Cancer.
[25] Wei Zhang,et al. Diagnostic value of whole‐body magnetic resonance imaging for bone metastases: a systematic review and meta‐analysis , 2011, Journal of magnetic resonance imaging : JMRI.
[26] R K Sachs,et al. Radiation-induced cancer: a modern view. , 2012, The British journal of radiology.
[27] J. Stoker,et al. Whole-body magnetic resonance imaging for detection of skeletal metastases in children and young people with primary solid tumors - systematic review , 2017, Pediatric Radiology.
[28] E. Lang,et al. Effect of team training on patients' ability to complete MRI examinations. , 2010, Academic radiology.
[29] Li Zhang,et al. Comparison of FDG PET/CT and Gadolinium-Enhanced MRI for the Detection of Bone Metastases in Patients With Cancer: A Meta-analysis , 2013, Clinical nuclear medicine.
[30] G. Norman,et al. Interpretation of Changes in Health-related Quality of Life: The Remarkable Universality of Half a Standard Deviation , 2003, Medical care.
[31] I. Swift,et al. Local staging and assessment of colon cancer with 1.5-T magnetic resonance imaging. , 2016, The British journal of radiology.
[32] Sofia Carlsson,et al. 'The situation and the uncertainty about the coming result scared me but interaction with the radiographers helped me through': a qualitative study on patients' experiences of magnetic resonance imaging examinations. , 2013, Journal of clinical nursing.
[33] Qiong Li,et al. Diagnostic value of whole-body diffusion-weighted magnetic resonance imaging for detection of primary and metastatic malignancies: a meta-analysis. , 2014, European Journal of Radiology.
[34] A. Dixon,et al. Patients' perceptions of magnetic resonance imaging. , 1995, Clinical radiology.
[35] D. Collins,et al. Inter- and Intra-Observer Repeatability of Quantitative Whole-Body, Diffusion-Weighted Imaging (WBDWI) in Metastatic Bone Disease , 2016, PloS one.
[36] S. Matsumoto,et al. Non-small cell lung cancer: whole-body MR examination for M-stage assessment--utility for whole-body diffusion-weighted imaging compared with integrated FDG PET/CT. , 2008, Radiology.
[37] E. Squillaci,et al. Staging of colon cancer: whole-body MRI vs. whole-body PET-CT—initial clinical experience , 2008, Abdominal Imaging.
[38] A. Dirksen,et al. Preoperative staging of lung cancer with combined PET-CT. , 2009, The New England journal of medicine.
[39] M. Parmar,et al. Lung cancer diagnosis and staging with endobronchial ultrasound-guided transbronchial needle aspiration compared with conventional approaches: an open-label, pragmatic, randomised controlled trial , 2015, The Lancet Respiratory Medicine.
[40] Stuart A. Taylor,et al. Patient experience and perceived acceptability of whole-body magnetic resonance imaging for staging colorectal and lung cancer compared with current staging scans: a qualitative study , 2017, BMJ Open.
[41] Gary Poole,et al. Claustrophobia and the Magnetic Resonance Imaging Procedure , 1998, Journal of Behavioral Medicine.
[42] P. Summers,et al. Whole-body diffusion-weighted imaging: is it all we need for detecting metastases in melanoma patients? , 2013, European Radiology.
[43] H. Turunen,et al. Content analysis and thematic analysis: Implications for conducting a qualitative descriptive study. , 2013, Nursing & health sciences.
[44] H. Imhof,et al. A study of the effects of patient anxiety, perceptions and equipment on motion artifacts in magnetic resonance imaging. , 1997, Magnetic resonance imaging.
[45] D. Sargent,et al. Progression-free survival is a surrogate for survival in advanced colorectal cancer. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[46] Li Xu,et al. Differential diagnosis between hepatic metastases and benign focal lesions using DWI with parallel acquisition technique: a meta-analysis , 2015, Tumor Biology.
[47] Michael Forsting,et al. Simultaneous Positron Emission Tomography/Magnetic Resonance Imaging for Whole-Body Staging in Patients With Recurrent Gynecological Malignancies of the Pelvis: A Comparison to Whole-Body Magnetic Resonance Imaging Alone , 2014, Investigative radiology.
[48] Steve Halligan,et al. Diagnostic accuracy of whole-body MRI versus standard imaging pathways for metastatic disease in newly diagnosed colorectal cancer: the prospective Streamline C trial , 2019, The lancet. Gastroenterology & hepatology.
[49] G. Shen,et al. Performance of DWI in the Nodal Characterization and Assessment of Lung Cancer: A Meta-Analysis. , 2016, AJR. American journal of roentgenology.
[50] C. Compton,et al. AJCC Cancer Staging Manual , 2002, Springer New York.
[51] Evis Sala,et al. METastasis Reporting and Data System for Prostate Cancer: Practical Guidelines for Acquisition, Interpretation, and Reporting of Whole-body Magnetic Resonance Imaging-based Evaluations of Multiorgan Involvement in Advanced Prostate Cancer☆ , 2017, European urology.
[52] Cyprian Olchowy,et al. The presence of the gadolinium-based contrast agent depositions in the brain and symptoms of gadolinium neurotoxicity - A systematic review , 2017, PloS one.
[53] J. Wardle,et al. Patient acceptability of CT colonography compared with double contrast barium enema: results from a multicentre randomised controlled trial of symptomatic patients , 2011, European Radiology.
[54] R. Kadavigere,et al. Accuracy of Whole-Body DWI for Metastases Screening in a Diverse Group of Malignancies: Comparison With Conventional Cross-Sectional Imaging and Nuclear Scintigraphy. , 2017, AJR. American journal of roentgenology.
[55] S. Halligan,et al. Perceived patient burden and acceptability of whole body MRI for staging lung and colorectal cancer; comparison with standard staging investigations , 2018, The British journal of radiology.
[56] J. Prins,et al. The faster the better?—A systematic review on distress in the diagnostic phase of suspected cancer, and the influence of rapid diagnostic pathways , 2012, Psycho-oncology.
[57] M. Chung,et al. Nodal metastasis in non-small cell lung cancer: accuracy of 3.0-T MR imaging. , 2008, Radiology.
[58] Ying Hu,et al. Comparison of whole-body MRI and skeletal scintigraphy for detection of bone metastatic tumors: a meta-analysis. , 2013, Surgical oncology.
[59] E. Haacke,et al. Preoperative mediastinal and hilar nodal staging with diffusion-weighted magnetic resonance imaging and fluorodeoxyglucose positron emission tomography/computed tomography in patients with non-small-cell lung cancer: which is better? , 2012, The Journal of surgical research.
[60] Maarten J. IJzerman,et al. Statistical Methods for the Analysis of Discrete Choice Experiments: A Report of the ISPOR Conjoint Analysis Good Research Practices Task Force. , 2016, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
[61] Hui-lin Yang,et al. Fluorine-18 deoxyglucose positron emission tomography, magnetic resonance imaging and bone scintigraphy for the diagnosis of bone metastases in patients with lung cancer: which one is the best?--a meta-analysis. , 2011, Clinical oncology (Royal College of Radiologists (Great Britain)).
[62] M. Dewey,et al. Claustrophobia during magnetic resonance imaging: Cohort study in over 55,000 patients , 2007, Journal of magnetic resonance imaging : JMRI.
[63] Gordon H Guyatt,et al. Methods to explain the clinical significance of health status measures. , 2002, Mayo Clinic proceedings.
[64] D. Brenner,et al. Cancer risks from diagnostic radiology. , 2008, The British journal of radiology.
[65] J. Carlin,et al. Bias, prevalence and kappa. , 1993, Journal of clinical epidemiology.
[66] Z. He,et al. Comparison of FDG whole-body PET/CT and gadolinium-enhanced whole-body MRI for distant malignancies in patients with malignant tumors: a meta-analysis. , 2013, Annals of oncology : official journal of the European Society for Medical Oncology.
[67] Hans Weda,et al. Pinpointing Moments of High Anxiety During an MRI Examination , 2013, International Journal of Behavioral Medicine.
[68] K. Verstraete,et al. Value of whole body MRI and dynamic contrast enhanced MRI in the diagnosis, follow-up and evaluation of disease activity and extent in multiple myeloma. , 2013, European journal of radiology.
[69] O. Gureje,et al. The validity of two versions of the GHQ in the WHO study of mental illness in general health care , 1997, Psychological Medicine.
[70] T. Kwee,et al. Whole-body MRI vs. CT for staging lymphoma: patient experience. , 2014, European journal of radiology.
[71] P. Bossuyt,et al. Assessing the value of diagnostic tests: a framework for designing and evaluating trials , 2012, BMJ : British Medical Journal.
[72] D. Watson,et al. Development and validation of brief measures of positive and negative affect: the PANAS scales. , 1988, Journal of personality and social psychology.
[73] T. Bekaii-Saab,et al. Clinical Trials and Progress in Metastatic Colon Cancer. , 2018, Surgical oncology clinics of North America.
[74] P. Babyn,et al. Whole-body MR imaging for staging of malignant tumors in pediatric patients: results of the American College of Radiology Imaging Network 6660 Trial. , 2013, Radiology.
[75] Lianming Wu,et al. A meta-analysis of ¹⁸FDG-PET-CT, ¹⁸FDG-PET, MRI and bone scintigraphy for diagnosis of bone metastases in patients with lung cancer. , 2012, European journal of radiology.
[76] R. Shortman,et al. A comparison of the psychological burden of PET/MRI and PET/CT scans and association to initial state anxiety and previous imaging experiences. , 2015, The British journal of radiology.
[77] M. Offringa,et al. Reporting of interventions and “standard of care” control arms in pediatric clinical trials: a quantitative analysis , 2018, Pediatric Research.
[78] Elna-Marie Larsson,et al. It's like being in another world--patients' lived experience of magnetic resonance imaging. , 2006, Journal of clinical nursing.
[79] D. Koh,et al. Whole-Body MRI: Current Applications in Oncology. , 2017, AJR. American journal of roentgenology.
[80] J. R. Landis,et al. The measurement of observer agreement for categorical data. , 1977, Biometrics.
[81] Steve Halligan,et al. Diagnostic accuracy of whole-body MRI versus standard imaging pathways for metastatic disease in newly diagnosed non-small-cell lung cancer : the prospective Streamline L trial , 2019 .